| |
|
|
| Year : 2009 | Volume
: 20
| Issue : 3 | Page : 375-377 |
|
| Impact of obesity on development of chronic renal allograft dysfunction |
|
|
Alireza Hamidian Jahromi1, Ghanbar Ali Raiss Jalali2, Jamshid Roozbeh3
1 Oxford, Transplant Center, The Churchill Hospital, Roosevelt Drive Headington, Oxford, United Kingdom; Nemazee Hospital Organ Transplantation Unit, Shiraz University of Medical Sciences, Shiraz, Iran
2 Oxford, Transplant Center, The Churchill Hospital, Roosevelt Drive Headington, Oxford, United Kingdom
3 Nemazee Hospital Organ Transplantation Unit, Shiraz University of Medical Sciences, Shiraz, United Kingdom
Click here for correspondence address and email
|
|
 |
|
 Abstract | | |
Obesity in nontransplant patients has been associated with hypertension, hyperlipidemia, diabetes, and proteinuria. To determine whether renal transplant recipients with an elevated BMI have worse long term graft survival, we prospectively studied 92 patients transplanted between April 1999 and July 2000. Weight (Wt) and height of the patients were recorded prior to transplantation and two weeks, one, two and three years post transplantation. Blood urea nitrogen (BUN), creatinine (Cr) and blood pressure were checked monthly, while triglyceride, cholesterol, high density lipoprotein (HDL), and low density lipoprotein (LDL) were obtained 3 monthly for 3 years post transplantation. Graft dysfunction was defined as serum Cr > 1.8 mg/dL. While BMI and Wt of the patients before transplantation did not show any significant correlation with chronic renal allograft dysfunction (CRAD), patients with higher Wt and BMI two weeks after transplantation showed an increased risk of developing CRAD during the three year post transplant independent of other risk factors (P< 0.05). Patients with greater Wt loss in the first two weeks post transplantation showed a decreased risk of developing CRAD in the following 3 years (P< 0.001). Our study suggests that high Wt and BMI are significantly associated with worse graft survival 3 years post renal transplantation. Keywords: Renal transplantation, Chronic renal allograft dysfunction, Obesity, Body mass index, Outcome
How to cite this article:
Jahromi AH, Jalali GA, Roozbeh J. Impact of obesity on development of chronic renal allograft dysfunction. Saudi J Kidney Dis Transpl 2009;20:375-7 |
How to cite this URL:
Jahromi AH, Jalali GA, Roozbeh J. Impact of obesity on development of chronic renal allograft dysfunction. Saudi J Kidney Dis Transpl [serial online] 2009 [cited 2022 Jul 2];20:375-7. Available from: https://www.sjkdt.org/text.asp?2009/20/3/375/50759 |
| Introduction | |  |
Advancements in renal transplantation have dramatically improved outcome, especially one year graft survival rates for recipients with endstage renal diseases (ESRD). [1] Increased body mass index (BMI) is an important risk factor for death in the general population, and has also been linked to cardiovascular death. [2] Some stuies found an association between decreased survival and increased BMI in renal transplant recipients, [3] however, other studies could not such association. [4],[5],[6] Obesity in non-transplant patients has been associated with hypertension, hyper-lipidemia, diabetes, proteinuria, and glomerulopathy. [7],[8]
We aim in this study to determine whether BMI is associated with decreased long term survival in renal transplant recipient.
| Patients and Methods | | |
This prospective study included 92 patients (M=50, F=42) transplanted in our center between April 1999 and July 2000. Weight (Wt) and height of the patients were recorded prior to transplantation and two weeks, one, two and three years post transplantation. The dialysis duration before transplantation and medications were recorded. Blood urea nitrogen (BUN), serum creatinine (Cr) and blood pressure were checked monthly; triglyceride (TG), cholesterol, high density lipoprotein (HDL), and low density lipoprotein (LDL) 3-monthly for 3 years post transplantation. In this study, graft dysfunction was defined as serum Cr > 1.8 mg/dL, hypertriglyceridemia as serum TG > 250 mg/dL, and hypercholesterolemia as serum cholesterol > 200 mg/dL. Hypertension was defined as BP > 140/90 on two occasions or being on antihypertensive medications.
Statistical Analysis
Results were analyzed by SPSS-10 software and for interpretation of results. Student "t" test, chi square, phi and Cramer test were used when indicated and P< 0.05 was defined as statistically significant.
| Results | | |
The mean age of recipients was 35.3 ± 9.8 years (range 16-58 years). Eleven patients received organs from deceased donors, 49 from living related donors (LRD), 12 from living unrelated donors (LURD) and 20 from spouses. Demographic features of the study patients are shown in [Table 1].
The mean BMI of the patients was 21.4 ± 6.9 kg/m 2 (range 12.0-46.7 kg/m 2 ) and mean weight was 57.6 ± 15.2 kg (range 40.5-119.5 kg). The patients mean weight gain during 3 years time was 10.1 ± 7.4 kg (range 0-32 kg). BUN and creatinine of the patients prior to transplantation was 90 ± 29.8 mg/dL and 10.4 ± 4 mg/dL respectively. The patients were on dialysis for an average time of 4.7 ± 2.1 years before their transplantation. Development of renal allograft dysfunction did not show any association with the duration of dialysis (P= 0.21).
While BMI and Wt of the patients before transplantation did not show any significant correlation with chronic renal allograft dysfunction (CRAD) (P> 0.05), patients with higher Wt and BMI two weeks after transplantation showed an increased risk of developing CRAD in the three year post transplant period independent of other risk factors checked (P< 0.05). The mean BMI two weeks post transplantation was significantly higher in patients showing CRAD in the 3 years post transplantation period than patients without CRAD (mean BMI 23.3 ± 6.0 vs. 20.0 ± 5.4 kg/m 2 , P< 0.05).
The mean Wt loss in the first 2 week post operation period was 0.6 ± 0.4 kg in patients with CRAD compared with 1.1 ± 0.7 kg in patients without CRAD in the three years post transplant period. Patients with greater Wt loss in the first two weeks after transplantation showed more decreased risk of developing CRAD in the three years post transplant period (P< 0.001).
| Discussion | | |
Obesity continues to be a significant risk factor for morbidity and mortality in the general population. [9] Although obesity has been associated with improved survival on dialysis, the impact of obesity on graft survival after transplantation continues to be controversial. [3],[10],[11] Some studies have shown BMI to be a strong independent risk factor for graft failure independent of patient's death after renal transplantation. 3 However, others reported no significant correlation between obesity and graft survival for either deceased or living donor transplants. [11] Better outcome of obese patients on dialysis could be explained by more stable hemodynamic status, endotoxin lipoprotein interaction and protective effect of obesity on malnutrition in dialysis. [12],[13] We found BMI a strong independent risk factor for developing CRAD.
Previous studies have used pre transplant body weight for calculating BMI in the patients, which mainly might be affected by the amount of edema and inadequacy of the dialysis before transplantation. Our study results show that body weight 2 weeks post transplantation and when the transplanted kidney has started its function might be a better estimation of the dry weight of the patient and a better evaluation of the risk of allograft dysfunction.
Patients with greater Wt loss in the first two weeks post transplantation show a decreased risk of developing CRAD in the 3 year post transplantation. This might be due to a better function of transplanted kidney in these patients during the first two weeks post transplantation. It seems that better function of the transplanted graft at this stage might be associated with lower risk of developing CRAD.
Our study suggests that high Wt and BMI are significantly associated with worse graft survival 3 years post renal transplantation.
| Acknowledgement | | |
The authors would like to thank Ms. Samira Mazloom for her kind support in preparing the manuscript of this study.
| References | | |
| 1. | Mitsnefes MM, Khoury P, McEnery PT. Body mass index and allograft function in pediatric renal transplantation. Pediatr Nephrol 2002;17 (7):535-9.  |
| 2. | Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-105. |
| 3. | Meier-Kriesche H, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death. Transplantation 2002;73:70-4. |
| 4. | Hanevold CD, Ho PL, Talley L, Mitsnefes MM. Obesity and renal transplant outcome: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 2005; 115:352-6. [PUBMED] [FULLTEXT] |
| 5. | Massarweh NN, Clayton JL, Mangum CA, Florman SS, Slakey DP. High body mass index and short and long term renal allograft survival in adults. Transplantation 2005;80:1430-4. |
| 6. | Singh D, Lawen J, Alkhudair W. Does pretransplant obesity affect the outcome in kidney transplant recipients. Transplant Proc 2005;37: 717-20. [PUBMED] [FULLTEXT] |
| 7. | Hall JE, Brands MW, Henegar JR. Mechanisms of hypertension and kidney disease in obesity. Ann NY Acad Sci 1999;892:91-107. [PUBMED] [FULLTEXT] |
| 8. | Kambham N, Markowits GS, Valeri AM, Lin J, D'Agati VD. Obesity related glomerulopathy: An emerging epidemic. Kidney Int 2001;59: 1498-509. |
| 9. | Byers T. Body weight and mortality. N Engl J Med 1995;333:723-4. |
| 10. | Kalantar-Zadeh K, Kopple JD. Obesity paradox in patients on maintenance dialysis. Contrib Nephrol 2006;151:57-69. |
| 11. | Drafts HH, Anjum MR, Wynn JJ, et al. The impact of pre-transplant obesity on renal transplant outcomes. Clin Transplant 1997;11: 493-6. [PUBMED] |
| 12. | Salahudeen AK. Obesity and survival on dialysis. Am J Kidney Dis 2003;41:925-32. [PUBMED] [FULLTEXT] |
| 13. | Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005;82:543-54. |
Correspondence Address:
Alireza Hamidian Jahromi
Senior House Officer in Transplant, Oxford Transplant Centre, Churchill Hospital, Roosevelt Drive, Headington, Oxford OX3 7LJ, United Kingdom
 Source of Support: None, Conflict of Interest: None  | Check |
PMID: 19414937 
[Table 1] |
|
| This article has been cited by | | 1 |
Leptin, Insulin Resistance, and Metabolic Changes 5 Years After Renal Transplantation |
|
| Nicoletto, B.B. and Souza, G.C. and Gonçalves, L.F. and Costa, C. and Perry, I.S. and Manfro, R.C. | | Journal of Renal Nutrition. 2012; 22(4): 440-449 | | [Pubmed] | | | 2 |
Comparative effects of palm oil and palm oil mill effluent on hepatic and renal biomarkers levels in blood plasma of normo rats |
|
| Erukainure, O.L. and Ajiboye, J.A. and Adeboyejo, F.O. and Obode, O.C. and Okafor, E.N. | | Electronic Journal of Environmental, Agricultural and Food Chemistry. 2011; 10(10): 3006-3012 | | [Pubmed] | | | 3 |
Protective effect of Garcinia against renal oxidative stress and biomarkers induced by high fat and sucrose diet |
|
| Amin, K.A. and Kamel, H.H. and Abd Eltawab, M.A. | | Lipids in Health and Disease. 2011; 10(6) | | [Pubmed] | | | 4 |
Effect of Obesity on Physical Quality of Life after Renal Transplant |
|
| Udgiri, N. | | Journal of the American College of Surgeons. 2010; 211(1): 144-145 | | [Pubmed] | |
|
|
|
|
|
|
|
|
|
|
|
|
| Article Access Statistics | | | Viewed | 2791 | | | Printed | 102 | | | Emailed | 0 | | | PDF Downloaded | 556 | | | Comments | [Add] | | | Cited by others | 4 | | |
|
|
